The Cancer Genome Atlas (TCGA) study was the first landmark study to describe the mutation of EIF1AX (eukaryotic translation initiation factor 1A, X-linked) in thyroid tumors, more specifically in papillary thyroid carcinoma (PTC) [1]. This evidence concerns the gene EIF1AX and thyroid tumor.